Eastwood Bio-Medical Canada Inc. EBM.V
TSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 37.40% | 20.58% | -0.02% | 8.41% | -11.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.40% | 20.58% | -0.02% | 8.41% | -11.35% |
| Cost of Revenue | 13.35% | -8.10% | -8.80% | -9.23% | -14.94% |
| Gross Profit | 51.03% | 36.40% | 4.50% | 18.02% | -9.15% |
| SG&A Expenses | 10.67% | 3.76% | 5.83% | 3.31% | -11.52% |
| Depreciation & Amortization | -56.37% | -78.82% | -91.75% | -60.00% | -34.18% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.11% | -6.77% | -8.87% | -5.83% | -14.56% |
| Operating Income | 47.86% | 53.83% | 26.59% | 32.17% | 19.57% |
| Income Before Tax | 43.49% | 52.38% | 31.06% | 29.16% | 16.91% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.49% | 52.38% | 31.06% | 29.16% | 16.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.49% | 52.38% | 31.06% | 29.16% | 16.91% |
| EBIT | 47.86% | 53.83% | 26.59% | 32.17% | 19.57% |
| EBITDA | 45.58% | 45.07% | -8.53% | 21.18% | 18.54% |
| EPS Basic | 44.19% | 53.06% | 31.91% | 30.61% | 17.31% |
| Normalized Basic EPS | 48.15% | 54.84% | 33.33% | 29.03% | 18.18% |
| EPS Diluted | 44.19% | 53.06% | 31.91% | 30.61% | 17.31% |
| Normalized Diluted EPS | 48.15% | 54.84% | 33.33% | 29.03% | 18.18% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |